
We are the first HIPAA compliant platform that focuses on optimizing cancer treatment plans for patients in China locally. By connecting Chinese cancer patients to U.S. and Chinese oncologist and leveraging the existing medical facilities in China, we bring U.S. quality of care to Chinese cancer patients at less than 1/3 of the cost compared to medical travels to the U.S. Our pricing point is affordable by the top 40% of the income class in China.

We are the first HIPAA compliant platform that focuses on optimizing cancer treatment plans for patients in China locally. By connecting Chinese cancer patients to U.S. and Chinese oncologist and leveraging the existing medical facilities in China, we bring U.S. quality of care to Chinese cancer patients at less than 1/3 of the cost compared to medical travels to the U.S. Our pricing point is affordable by the top 40% of the income class in China.
Location: Philadelphia, Pennsylvania, United States
Product: HIPAA-compliant B2B platform for oncology treatment planning and remote consultation for Chinese patients
Founder / CEO: Kelly Xu
Employees: 9
Reported investors: Ventech China; Dongfang State-owned Assets (reported)
Cancer care access and treatment planning for Chinese patients
Health technology / Digital health
2600000.00 USD
Date and total funding amount present in company snapshot entry.
“Reported investors include Ventech China and Dongfang State-owned Assets”